was significantly increased in the post-sunitinib treated nephrectomy samples (Pvalue<0.001, logFC=0.8734; FDR=0.077, ) . Whereas, there was no significant change in methylation in VHL region 7896829 FDR=0.76) following clamping of the renal artery (devascularised nephrectomy sample). Indicating no effect of sampling on methylation of VHL region 789629.
Supplementary figure 3. Loss of heterozygosity plots. (a) Patients SU05-SU25, (b)
patients SU32-54. LOH occurring in all cells in a sample would result in germline heterozygous sites in the region covered by entirely reference or entirely alternate reads, which is evidenced by a B allele frequency (BAF: # alternate allele reads/total reads) of 0 or 1. An incomplete shift of the BAF away from 0.5 towards 0 or 1 indicates that not all cells in the sample have lost one copy of the locus (highlighted regions). This is no plot for sample SU16 as there was no normal sample from which to derive LOH.
Supplementary figure 4. Phylogenetic trees based on SNPs, indels and CNVs created using neighbour joining. (a) Patients SU05-SU23, (b) patients SU25-54.
The branch lengths include passenger mutations as well as drivers. Branch and trunk length are proportional to the number of mutations acquired on the corresponding branch or trunk (blue line for germline trunk edges, black for internal edges, and red for private mutations). Driver mutations were acquired by the indicated genes in the branches the arrows indicate. For branch with no labels, there were only passenger mutations defining that branch. Trees are rooted at the germline DNA sequence, determined by sequencing of DNA from normal renal tissue. These trees demonstrate that despite relative homogeneity of mutation status between biopsy and nephrectomy samples there is variability between samples from the same patient. The scale bar shows the branch length corresponding to 1 mutation. Damaging mutations to VHL were included (frameshifts; in-frame insertions and deletions; nonsense mutations and missense mutations predicted to be damaging). This table details the methylation differences in the 48 key ccRCC genes following patient treatment with sunitinib. 'Label' is the target gene label, 'logFC' is the fold change log, and, 'FDR' is the Benjamini-Hochberg adjusted P-value. VHL is the only target that has a false discovery rate (FDR) under the 0.1 significance level. 
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VHL mutation VHL hypermethylation
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